A pharmaceutical composition comprising palmitoylethanolamid and cytidine-diphosphocholine

摘要

The object of the present invention is a pharmaceutical composition for use in humans or animals containing N-palmitoylethanolamide and Cytidine-diphosphocholine for the treatment of pathologies of the Central Nervous System of a traumatic, vascular, degenerative nature associated with neurodegeneration. In particular, the present invention concerns a pharmaceutical composition comprising palmitoylethanolamide (PEA) and Cytidine-diphosphocholine (CDP-Choline or Citicoline), possibly with the addition of an antioxidant compound such as for example a polyphenol, alpha-lipoic acid or L-acetylcysteine.